SB 17-032

failed

Prescription Drug Monitoring Program Access

Plain-English Summary

AI-generated

Senate Bill 17-032, which has been signed into law, changes how law enforcement and state regulatory boards can access the Prescription Drug Monitoring Program (PDMP). Currently, these entities need a court order or subpoena to view PDMP data. The new law requires them to obtain either an official court order or warrant based on probable cause, making it harder for them to access this information without sufficient evidence of wrongdoing. This affects how prescription drug abuse and fraud are investigated by tightening the criteria for accessing sensitive patient medication records.

Official Summary

Current law gives law enforcement officials and state regulatory boards access to the prescription drug monitoring program with a request that is accompanied by an official court order or subpoena. The bill changes this requirement to an official court order or warrant issued upon a showing of probable cause. (Note: This summary applies to this bill as introduced.)

Details

Chamber: Senate
First action: 2017-02-01
Latest action: 2017-01-11
Last action desc.: Introduced In Senate - Assigned to Judiciary
OpenStates: View source ↗

Votes

Adopt amendment L.001 (Attachment B). The motion passed without objection.

2017-02-01 · House · pass — Yes: 0 · No: 0 · Other: —

Refer Senate Bill 17-032, as amended, to the Committee on Finance. The motion failed on a vote of 2-3.

2017-02-01 · House · fail — Yes: 2 · No: 3 · Other: —

Postpone Senate Bill 17-032 indefinitely using a reversal of the previous roll call. There was no objection to the use of the reverse roll call, therefore, the bill was postponed indefinitely. The motion passed without objection.

2017-02-01 · House · pass — Yes: 0 · No: 0 · Other: —